Elmeligy, Hesham A.
Azzam, Ahmed M.
Ossama, Yousra
Rady, Mahmoud
Funding for this research was provided by:
Theodor Bilharz Research Institute
Article History
Received: 4 October 2024
Accepted: 1 April 2025
First Online: 9 May 2025
Declarations
:
: The study was approved by the Research Ethics Committee at Theodor Bilharz Research Institute, Egypt (Approval Number: PT-658), and informed consent was obtained from the patients through the institutional consent form, which included permission to use their data for research purposes. Also, the trial registration was recorded as: ClinicalTrial.gov Identifier No.: NCT06630910 at 10/05/2024, and our study is adhered to the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.